[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592084":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":26,"locations":26,"responsibleParty":31,"collaborators":35,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":40,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":26,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":64,"whyStopped":26,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":26},{"fullName":5,"class":6},"King Edward Medical University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1","EXPERIMENTAL","G-CSF plus antibiotic therapy",[13],"Drug: G-CSF",{"label":15,"type":16,"description":17,"interventionNames":18},"Group 2","ACTIVE_COMPARATOR","Antibiotic Therapy",[19],"Drug: Antibiotics only",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","G-CSF","G-CSF \\& Antibiotic therapy in combination",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Antibiotics only","Antibiotics alone",[15],{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Sidrah Lodhi","Assistant Professor of Endocrinology",[36],{"name":37,"class":6},"University of Child Health Sciences and Children's Hospital, Lahore","100592084","phase-4-comparison-of-g-csf--antibiotics-versus-antibiotics-alone-in-resolution-of-febrile-neutropenia-100592084",false,"NCT06988826","Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile Neutropenia","Comparison of Antibiotics With and Without Granulocyte Colony-Stimulating Factor in Children With Chemotherapy Induced Febrile Neutropenia","AGF-FN","Inclusion Criteria:\n\n* Age 1-16 years\n* any Gender\n* Febrile neutropenia\n* diagnosed case of solid or hematological malignancy\n* taking chemotherapy\n\nExclusion Criteria:\n\n* Non-neutropenic fever\n* already received G-CSF or antibiotics before presenting to hospital\n* any other cause of neutropenia","ALL","1 Year","16 Years",{"count":50,"type":51},150,"ESTIMATED","INTERVENTIONAL",[54],"PHASE4","This study aim to find the best option for children having cancer who develop low immunity state due to chemotherapy",[57,58,59,23,17],"Febrile Neutropenia","Febrile Neutropenia, Rule of Clinical Decision, Chemotherapy","Febrile Neutropenia, Drug-Induced",[61,62,63,23],"febrile neutropenia","chemotherapy-induced febrile neutropenia","Antibiotics","NOT_YET_RECRUITING","2025-05-23",{"date":67,"type":68},"2025-05-25","ACTUAL",{"date":70,"type":51},"2025-06-01",{"date":72,"type":51},"2026-12",{"name":5,"class":6}]